Download
1 / 15

April 2008, Belfast - PowerPoint PPT Presentation


  • 111 Views
  • Uploaded on

BHIVA 14th Annual Conference. April 2008, Belfast. Belfast Waterfront Hall. BHIVA 14th Annual Conference. 500 delegates 200 Poster presentations 30 oral abstracts 10 Satellite symposiums 5 Plenary sessions 3 big workshops

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' April 2008, Belfast' - star


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

BHIVA 14th Annual Conference

April 2008, Belfast

Belfast Waterfront Hall


Bhiva 14th annual conference
BHIVA 14th Annual Conference

  • 500 delegates

  • 200 Poster presentations

  • 30 oral abstracts

  • 10 Satellite symposiums

  • 5 Plenary sessions

  • 3 big workshops

  • Presentation of awards for 3 best abstracts of the conference by the Mayor of Belfast.


Relevant abstracts
Relevant abstracts

  • Immunotherapy while delaying HAART

  • 350 CD4 threshold for starting therapy

  • Protease Inhibitors monotherapy

  • Diagnosing the undiagnosed

  • Ageing of the PLH population

  • HIV treatment adherence for adolescents

  • Community HIV treatment adherence support

  • The importance of home delivery for ARVs


Diagnosing the undiagnosed
Diagnosing the undiagnosed

  • Targeted prevention

    • Communities

    • Primary Care HIV testing

  • Background

    • CDC – routine testing of 13-64 olds to reduce late presentations

  • Methods

    • Past diagnosed prevalence for MSM and HS

      MSM - 0.25% prevalence and black women 2%


Diagnosing the undiagnosed1
Diagnosing the undiagnosed

  • Conclusion

    • Localised approach of targeting offers HIV testing based on simple risk assessments.

    • It allows local patient acceptability, setting appropriateness and partner notification.


Protease inhibitors mono therapy the kimodo study
Protease Inhibitors mono-therapyThe KIMODO Study

  • Kaletra (Lopinavir + Ritonavir) monotherapy

  • Kaletra + Sustiva/Neviralpine

  • No significant difference between the two

  • Benefits

    • Less toxicity

    • Better adherence

    • Better resistance profile




Ageing of the plh population
Ageing of the PLH population

  • Cardiovascular disease

  • Diabetes

  • Dementia

  • Physical weakness

    • Care for elderly

    • Mobility

  • Sensory impairment

  • Living will/Funeral arrangements…


New drugs
New Drugs

  • Celsentri (Maraviroc) – CCR5 antagonist

  • Isentress (Raltegravir) – Integrase inhibitor

  • Atripula od (Tenofovir+ Emtrica +Sustiva)


ad